Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ernexa Therapeutics

Request full access

Harnessing the power of cytokines to restore immune function

New York City, United StatesFounded 1994Biotech & Life Sciences

About Ernexa Therapeutics

Brooklyn ImmunoTherapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for cancer and immunologic diseases. The company's primary focus is on IRX-2, a novel human cell-derived hd IL-2 based therapy designed to restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. IRX-2 has shown promising results in Phase 2a clinical trials for head and neck cancer, demonstrating an increase in tumor-infiltrating lymphocytes and an associated survival benefit. Brooklyn ImmunoTherapeutics operates in the biopharmaceutical market, targeting healthcare providers and researchers specializing in oncology and immunotherapy. The company generates revenue through partnerships, grants, and potential future sales of its therapeutic products.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2021

Ernexa Therapeutics in the New York City ecosystem

Live from Dealroom

The Ernexa Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · New York City HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ernexa Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ernexa Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.